Publication:
Recreational Drugs and the Risk of Hepatocellular Carcinoma.

dc.contributor.authorPinazo-Bandera, José M
dc.contributor.authorGarcía-Cortés, Miren
dc.contributor.authorSegovia-Zafra, Antonio
dc.contributor.authorLucena, María Isabel
dc.contributor.authorAndrade, Raúl J
dc.date.accessioned2023-05-03T13:52:00Z
dc.date.available2023-05-03T13:52:00Z
dc.date.issued2022-11-02
dc.description.abstractRecreational or aesthetic drug use is a distinctive behavior of humans, principally attested in the last century. It is known that recreational and illegal drugs are major contributors to the universal morbidity rate worldwide. Many of these substances have a well-established hepatotoxic potential, causing acute or chronic liver injury, liver fibrosis and cirrhosis, but their implications for hepatocellular carcinoma or other varieties of liver tumors are little known. In this article, we perform an extensive literature review, aiming to provide updated information about recreational drug use and the risk of developing liver tumors. Khat use and pyrrolizidine alkaloid consumption (present in some natural plants) have been linked to liver cirrhosis. Kava intake is associated with different liver tumors in animal models but not in humans. Cannabis' potential to accelerate liver fibrosis in chronic hepatitis is controversial according to the existing data. Cigarette smoking is an important contributor to hepatocellular carcinoma, and anabolic androgen steroids are well-defined causes of a variety of liver cancers and other hepatic tumors. Long-term follow-up studies of subjects who have developed injuries in association with the use of recreational drugs are warranted so as to better define the risk of developing hepatocellular carcinoma in association with these substances and, thus, to implement health care policies to combat this preventable cause of cancer.
dc.identifier.doi10.3390/cancers14215395
dc.identifier.issn2072-6694
dc.identifier.pmcPMC9657889
dc.identifier.pmid36358813
dc.identifier.pubmedURLhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9657889/pdf
dc.identifier.unpaywallURLhttps://www.mdpi.com/2072-6694/14/21/5395/pdf?version=1667377622
dc.identifier.urihttp://hdl.handle.net/10668/20925
dc.issue.number21
dc.journal.titleCancers
dc.journal.titleabbreviationCancers (Basel)
dc.language.isoen
dc.organizationHospital Universitario Virgen de la Victoria
dc.organizationHospital Universitario Virgen de la Victoria
dc.organizationHospital Universitario Virgen de la Victoria
dc.organizationInstituto de Investigación Biomédica de Málaga-IBIMA
dc.pubmedtypeJournal Article
dc.pubmedtypeReview
dc.rightsAttribution 4.0 International
dc.rights.accessRightsopen access
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.subjecthepatocellular carcinoma
dc.subjectherbals
dc.subjectillicit drugs
dc.subjectrecreational drugs
dc.titleRecreational Drugs and the Risk of Hepatocellular Carcinoma.
dc.typeresearch article
dc.type.hasVersionVoR
dc.volume.number14
dspace.entity.typePublication

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
PMC9657889.pdf
Size:
776.45 KB
Format:
Adobe Portable Document Format